General Information
BounceWatch is an independent company data service, not affiliated with Ad Scientiam. To contact Ad Scientiam, visit adscientiam.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Ad Scientiam compare?
A PDF of Ad Scientiam and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Ad Scientiam soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Ad Scientiam on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
France Market
Health Care
About Ad Scientiam
Business keywords: digital biomarkers, medical device, real world data, mHealth, ehealth, Connected Health, neuroscience, rare diseases, mental disorders, multiple sclerosis, Alzheimer's Disease, Parkinson's Disease, Rheumatoid Arthritis, patient monitoring, clinical research
Services & Products
Target Customers
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | €2.00M | - |
|
18 Jul 2017 |
| Non Equity Assistance | Undisclosed | - |
|
01 Sep 2015 |
Ad Scientiam Alternatives & Competitors
View All AlternativesBreakthrough is a Berlin-based startup building privacy-focused apps to help people with chronic dis...
Engaged Patients. Better Trials.
Here, no one goes at it alone. Join us to help our members heal together, get answers and take charg...
FAQ About Ad Scientiam
Source: BounceWatch company record for Ad Scientiam, https://bouncewatch.com/company/ad-scientiam, updated 11 June 2025. When citing, please name BounceWatch and link this page.